Manufacture of LNPs for RNA delivery

Manufacture of LNPs for RNA delivery

Nobel Prize lecture: Drew Weissman, Nobel Prize in Physiology or Medicine 2023Подробнее

Nobel Prize lecture: Drew Weissman, Nobel Prize in Physiology or Medicine 2023

Sanofi – The role of Lipid Nanoparticles (LNPs)Подробнее

Sanofi – The role of Lipid Nanoparticles (LNPs)

Lipid nanoparticles for RNA deliveryПодробнее

Lipid nanoparticles for RNA delivery

Manufacturing Lipid Nanoparticle nanoemulsion LNP Liposome 리포좀 RNA Delivery solid lipid nanoparticleПодробнее

Manufacturing Lipid Nanoparticle nanoemulsion LNP Liposome 리포좀 RNA Delivery solid lipid nanoparticle

Optimizing RNA Therapeutics - Virtual EventПодробнее

Optimizing RNA Therapeutics - Virtual Event

Enabling mRNA Delivery: How to Solve LNP Formulation ChallengesПодробнее

Enabling mRNA Delivery: How to Solve LNP Formulation Challenges

RNA-LNP Therapeutics Panel DiscussionПодробнее

RNA-LNP Therapeutics Panel Discussion

Scale up vaccines manufacturing from lab to production with Microfluidics 백신제조 백신생산 LNP RNA DeliveryПодробнее

Scale up vaccines manufacturing from lab to production with Microfluidics 백신제조 백신생산 LNP RNA Delivery

Optimized and Scalable LNP Composition for RNA Vaccine DeliveryПодробнее

Optimized and Scalable LNP Composition for RNA Vaccine Delivery

Microfluidizer® Technology for Producing RNA Delivery Platforms 백신제조 LNP Liposome nanoemulsionПодробнее

Microfluidizer® Technology for Producing RNA Delivery Platforms 백신제조 LNP Liposome nanoemulsion

PharmTech | Key Considerations When Selecting a mRNA CDMO PartnerПодробнее

PharmTech | Key Considerations When Selecting a mRNA CDMO Partner

Science & serendipity: lipid nanoparticles that enable COVID-19 mRNA vaccines - Gairdner LecturesПодробнее

Science & serendipity: lipid nanoparticles that enable COVID-19 mRNA vaccines - Gairdner Lectures

New Approaches for LNP Design and Microfluidic Manufacturing for Vaccines and CAR T Cell TherapyПодробнее

New Approaches for LNP Design and Microfluidic Manufacturing for Vaccines and CAR T Cell Therapy

2022 University of Manitoba Gairdner Lecture by Dr. Pieter CullisПодробнее

2022 University of Manitoba Gairdner Lecture by Dr. Pieter Cullis

Accelerate development by outsourcing MRNA–LNP formulations to a CDMOПодробнее

Accelerate development by outsourcing MRNA–LNP formulations to a CDMO

Transient Expression of mRNA Lipid Nanoparticle-based Chimeric Antigen Receptors for ImmunotherapyПодробнее

Transient Expression of mRNA Lipid Nanoparticle-based Chimeric Antigen Receptors for Immunotherapy

CAR T Cell Therapy with a Scalable RNA Lipid Nanoparticle PlatformПодробнее

CAR T Cell Therapy with a Scalable RNA Lipid Nanoparticle Platform

CMC Considerations for Developing an Effective mRNA/LNP TherapeuticПодробнее

CMC Considerations for Developing an Effective mRNA/LNP Therapeutic

Developing a platform process for LNP manufactureПодробнее

Developing a platform process for LNP manufacture